Skip to content

Earnings Screener Charts Portfolio Pricing

Connect your AI

Stocks
Eton Pharmaceuticals, Inc.
Business Segments
Products & Services
Payments To Acquire Marketing Rights

Payments To Acquire Marketing Rights

Eton Pharmaceuticals, Inc.·Products & Services·2 segments

Breakdown

Segments

HemangeolView metric

Uridine TriacetateView metric

Explore

Earnings Calendar
Stock Screener
Metrics Screener
Charts
Watchlist
Portfolio

Resources

Pricing
Releases
About
Contact
Methodology
Cite & Reuse
Sign in / Sign up

Connect

Claude
Claude Code
ChatGPT
Codex
Codex CLI
Cursor
Other clients

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

Segment	Q1 '26
Hemangeol	$14M
Uridine Triacetate	$1M
Total	$14M